New methodological approach for precision drug design in transthyretin amyloidosis
January 09, 2026
January 09, 2026
BARCELONA, Spain, Jan. 9 -- The Autonomous University of Barcelona issued the following news:
* * *
New methodological approach for precision drug design in transthyretin amyloidosis
*
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause transthyretin amyloidosis (ATTR), a group of fatal progressive diseases. The results, obtained thanks to a new methodologi . . .
* * *
New methodological approach for precision drug design in transthyretin amyloidosis
*
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause transthyretin amyloidosis (ATTR), a group of fatal progressive diseases. The results, obtained thanks to a new methodologi . . .